WELLS FARGO & COMPANY/MN - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 111 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$37,800
-33.7%
342,084
-1.4%
0.00%
Q3 2022$57,000
-35.2%
346,900
-0.0%
0.00%
Q2 2022$88,000
-38.0%
346,906
+29.5%
0.00%
Q1 2022$142,000
-10.1%
267,823
+3.8%
0.00%
Q4 2021$158,000
-38.5%
258,120
+2.8%
0.00%
Q3 2021$257,000
-12.6%
251,061
+56.4%
0.00%
Q2 2021$294,000
+23.5%
160,563
+32.5%
0.00%
Q1 2021$238,000
+93.5%
121,172
+23.4%
0.00%
Q4 2020$123,000
-64.8%
98,195
-49.4%
0.00%
Q3 2020$349,000
-76.0%
193,963
+11.9%
0.00%
Q2 2020$1,454,000
+115.4%
173,305
+34.5%
0.00%
Q1 2020$675,000
+2.3%
128,877
+6.6%
0.00%
Q4 2019$660,000
+13.8%
120,913
+1.4%
0.00%
Q3 2019$580,000
-19.1%
119,187
+15.1%
0.00%
Q2 2019$717,000
+6.7%
103,549
+7.1%
0.00%
Q1 2019$672,000
+25.6%
96,729
+5.5%
0.00%
Q4 2018$535,000
-16.8%
91,663
+7.8%
0.00%
Q3 2018$643,000
+45.5%
85,067
-2.6%
0.00%
Q2 2018$442,000
-10.3%
87,371
+8.2%
0.00%
Q1 2018$493,000
-11.3%
80,742
+3.0%
0.00%
Q4 2017$556,000
+46.7%
78,366
+48.2%
0.00%
Q3 2017$379,000
+2129.4%
52,893
+1859.0%
0.00%
Q2 2017$17,000
-22.7%
2,7000.0%0.00%
Q1 2017$22,000
+69.2%
2,700
+80.0%
0.00%
Q4 2016$13,000
-45.8%
1,500
-57.1%
0.00%
Q3 2016$24,0003,5000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders